Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Gleevec in children with multivessel intraluminal pulmonary vein stenosis
NCT00891527Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- Oct 2008
- Primary completion
- Dec 2015
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of bevacizumab and imatinib in pulmonary vein stenosis (PVS), sponsored by Boston Children's Hospital. Primary endpoint: Number of Patients With Survival at 48 Weeks. Started Oct 2008; status: completed.
02
Drugs
bevacizumabimatinib
03
Conditions
pulmonary vein stenosis (PVS)
Beyond the preview
Go deeper on NCT00891527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00891527.